Company / Current Assets
Praxis Precision Medicines, Inc. Current Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$610.9M
FY2025
5-year range
$84.9M / $610.9M
FY2021-FY2025
Trend
+51.1%
vs FY2024
Sector context
#97 of 213
Health Care
What the data says
At $611M, Praxis Precision Medicines, Inc.'s current assets ranks #97 of 213 in the Health Care sector. Improved from $85M to $611M over the past 2 years.
Based on SEC 10-K filings.
$611M in FY2025 with a 5-year CAGR of +15.1%.
Improved from $85M to $611M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +76.6%
- 5-Year CAGR
- +15.1%
- 10-Year CAGR
- -
Sector benchmark
#97 of 213 in Health CareTop 46% of 213This company $610.9M Sector average $2.5B
▼
-75.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +15.1%, indicating consistent growth.
- In FY2025, current assets increased 51.1% year-over-year.
- Ranks #97 out of 213 companies in the Health Care sector.
- Lowest current assets in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 4.48 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $610.9M | +51.1% |
| FY2024 | $404.4M | +376.4% |
| FY2023 | $84.9M | -23.4% |
| FY2022 | $110.8M | -61.4% |
| FY2021 | $287.4M | -4.9% |
| FY2020 | $302.3M | +564.5% |
| FY2019 | $45.5M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026